SCHEMBL5420384

SCHEMBL5420384

CCCC1(CC(=O)O)OCCc2c1sc1ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TSHR P16473 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
NFKB1 P19838 1/20 0.46
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
OPRM1 P35372 1/20 0.33
OGFRL1 Q5TC84 1/20 0.33
CYP1A2 P05177 1/20 0.33
SSTR3 P32745 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
CNR2 P34972 4/20 0.32
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
PTPN1 P18031 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5427095 0.93 TSHR (0.44) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5419195 0.91 ALDH1A1 (0.53) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5420257 0.85 ALDH1A1 (0.43) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5420858 0.81 TSHR (0.39) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5414937 0.78 TSHR (0.38) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL6530065 0.78 CYP1A2 (0.39) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5415334 0.78 ALDH1A1 (0.36) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5424845 0.77 CYP1A2 (0.39) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5417824 0.76 ALDH1A1 (0.38) ALDH1A1TSHRCYP3A4CYP2C9ALOX15
SCHEMBL5412720 0.75 ALDH1A1 (0.36) ALDH1A1TSHRCYP3A4CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276030-A1 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus WYETH (US) 2007-11-29 US claimed
WO-2005016932-A1 PYRANOBENZOTHIOPHENE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2005-02-24 WO claimed
US-20070276030-A1 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus WYETH (US) 2007-11-29 US disclosed
WO-2005016932-A1 PYRANOBENZOTHIOPHENE DERIVATIVES TO TREAT INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2005-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276030-A1 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus LIPC, HAVCR2, GTF3C2 ALDH1A1 767/4885TSHR 1214/4885CYP3A4 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.